As Overdose Deaths Climb, So Does Demand for Their AntidoteBy
Drugmakers drawn to market as governments expand access
Overdose reversals more than double last year from 2010
To contain a surge in drug-related deaths in the U.S., state and local governments are pouring money into programs to make an overdose antidote more widely available even as prices rise -- creating a growth opportunity for manufacturers.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.